The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Open accessAbstract
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decisive factor is that NF-κB-activation additionally causes a significantly increased resistance against apoptosis in aHSCs.[21]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cited by
Sorted by citations
Items 501–600 of 999
Daniel, P. V., Dogra, S., Rawat, P., Choubey, A., Khan, A. S., Rajak, S., Kamthan, M., & Mondal, P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100714 · Cited by 28
Control of Tissue Fibrosis by 5-Methoxytryptophan, an Innate Anti-Inflammatory Metabolite
Wu, K. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.759199 · Cited by 29
Adenosine receptor A2B mediates alcoholic hepatitis by regulating cAMP levels and the NF-KB pathway
Zhao, N. O., Xia, G., Cai, J.-N., Li, Z.-X., & Lv, X. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.01.012 · Cited by 28
The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
Ren, Y., Li, S., Song, Z., Luo, Q., Zhang, Y., & Wang, H. (2022) · Nutrients · doi:10.3390/nu14112303 · Cited by 30
Hao, R., Shan, S., Yang, D., Zhang, H., Sun, Y., & Li, Z. (2023) · Nutrients · doi:10.3390/nu15020372 · Cited by 28
Improvement of lipopolysaccharide‐induced hepatic injuries and inflammation with mulberry extracts
Ou, T., Kuo, C., Chyau, C.-C., Lee, H., Peng, J., & Wang, C. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5984 · Cited by 28
Liu, J., Sha, M., Wang, Q., Ma, Y., Geng, X., Gao, Y., Feng, L., Shen, Y., & Shen, Y. (2015) · BMC Cancer · doi:10.1186/s12885-015-1665-3 · Cited by 28
Lai, G. Y., Weinstein, S. J., Taylor, P. R., McGlynn, K. A., Virtamo, J. R. K., Gail, M. H., Albanes, D., & Freedman, N. D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.514 · Cited by 28
Tang, Y., Hu, C., & Liu, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.03.067 · Cited by 28
Parajuli, D. R., Zhao, Y., Jin, H., Chi, J. H., Li, S. Y., Kim, Y., Sohn, D. H., & Lee, S. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0425-2 · Cited by 28
Shokri, S., Mahmoudvand, S., Taherkhani, R., Farshadpour, F., & Jalilian, F. A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28249 · Cited by 28
Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical
Boyer‐Díaz, Z., Morata, P., Aristu-Zabalza, P., Gibert‐Ramos, A., Bosch, J., & Gracia‐Sancho, J. (2020) · Nutrients · doi:10.3390/nu12092627 · Cited by 28
Daoudaki, M., & Fouzas, I. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0296-7 · Cited by 28
Chen, N., Nishio, N., Ito, S., Tanaka, Y., Sun, Y., & Isobe, K. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1690-8 · Cited by 28
Antioxidant-independent activities of alpha-tocopherol
Chen, M., Ghelfi, M. D., Poon, J., Jeon, N., Boccalon, N., Rubsamen, M., Valentino, S. A., Mehta, V., Stamper, M., Tariq, H., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108327 · Cited by 33
Lin, H.-J., Chang, Y.-S., Lin, L.-H., Haung, C.-F., Wu, C.-Y., & Ou, K. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/916531 · Cited by 27
Amiya, T., Nakamoto, N., Chu, P., Teratani, T., Nakajima, H., Fukuchi, Y., Taniki, N., Yamaguchi, A., Shiba, S., Miyake, R., et al. (2016) · Scientific Reports · doi:10.1038/srep35146 · Cited by 28
Lisakovska, O., Shymanskyi, I., Mazanova, A., Khomenko, A., & Veliky, M. M. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0070 · Cited by 27
Managing cognitive symptoms and fatigue in cholestatic liver disease
Phaw, N. A., Leighton, J., Dyson, J. K., & Jones, D. E. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1844565 · Cited by 27
Angioni, R., Calì, B., Vigneswara, V., Crescenzi, M., Merino, A. M., Sánchez‐Rodríguez, R., Liboni, C., Hoogduijn, M. J., Newsome, P. N., Muraca, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228874 · Cited by 26
Zhang, Z., Wen, H., Peng, B., Weng, J., & Zeng, F. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.563265 · Cited by 27
Xiang, D., Yang, J., Xu, Y., Lan, L., Li, G., Zhang, C., & Liu, D. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119367 · Cited by 27
Nashar, E. M. E., Alghamdi, M. A., Alasmari, W. A., Hussein, M., Hamza, E., Taha, R., Ahmed, M. M., Al-Khater, K. M., & Abdelfattah‐Hassan, A. (2021) · Cells · doi:10.3390/cells10092475 · Cited by 27
Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
Zhang, Z., Liu, X., Shen, Z., Quan, J., Lin, C., Li, X., & Hu, G. M. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1983071 · Cited by 27
Hendawy, A. S., El-Lakkany, N. M., Mantawy, E. M., Hammam, O. A., Botros, S. S., & El‐Demerdash, E. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120695 · Cited by 28
Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
Villarruel-Melquiades, F., Mendoza‐Garrido, M. E., García-Cuellar, C. M., Sánchez-Pérez, Y., Pérez‐Carreón, J. I., & Camacho, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i17.2571 · Cited by 27
Wu, J., Li, M., Huang, N., Guan, F., Luo, H., Chen, L., Wei, G., Li, M., Lin, Z., Su, Z., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01067 · Cited by 27
LGR4 protects hepatocytes from injury in mouse
Li, Z., Liu, S., Lou, J., Mulholland, M. T., & Zhang, W. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00056.2018 · Cited by 27
Li, J., Zheng, S.-J., Wang, L., Liu, S., Ren, F., Chen, Y., Bai, L., Liu, M., & Duan, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7580 · Cited by 26
Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma
Wang, Z., Yan, M., Li, J., Long, J., Li, Y., & Zhang, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.11.016 · Cited by 25
Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury
Hsieh, Y., Lee, K., Wu, P.-S., Huo, T., Huang, Y., Hou, M., & Lin, H. (2021) · Cells · doi:10.3390/cells10061562 · Cited by 28
Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation
Wu, X., Dong, W., Kong, M., Ren, H., Wang, J., Shang, L., Zhu, Z., Zhu, W., & Shi, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680344 · Cited by 26
Zhao, J., Li, R., Li, J., Chen, Z., Lin, Z., Zhang, B., Deng, L., Chen, G., & Wang, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03689-w · Cited by 27
NAP1L5 targeting combined with MYH9 Inhibit HCC progression through PI3K/AKT/mTOR signaling pathway
Zhao, R., Ge, Y., Gong, Y., Li, B., Xiao, B., & Zuo, S. (2022) · Aging · doi:10.18632/aging.204377 · Cited by 26
Bolori, S., Shegefti, S., Baghaei, K., Yadegar, A., Moon, K., Foster, L. J., Nasiri, M. J., & Dabiri, H. (2023) · BioMed Research International · doi:10.1155/2023/4848643 · Cited by 26
Luo, J., Zhou, H., Wang, F., Xia, X., Sun, Q., Wang, R., & Cheng, B. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1842 · Cited by 26
Li, M., Mennone, A., Soroka, C. J., Hagey, L. R., Ouyang, X., Weinman, E. J., & Boyer, J. L. (2015) · Hepatology · doi:10.1002/hep.27956 · Cited by 22
Cholecystokinin protects mouse liver against ischemia and reperfusion injury
Zhang, Y., Zhu, J., Guo, L. Z., Zou, Y., Wang, F., Shao, H., Li, J., & Deng, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.03.028 · Cited by 26
Ji, D., Zhang, Y., Yao, S.-M., Zhai, X.-J., Zhang, L., Zhang, Y.-Z., & Li, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.016 · Cited by 26
Kim, J., Hyun, J., Wang, S., Lee, C., & Jung, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0762-z · Cited by 25
Wang, K., Chen, X.-Y., Zhang, R.-W.-Y., Yue, Y., Wen, X., Yang, Y., Han, C., Ma, Y., Liu, H., & Zhu, H. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122635 · Cited by 25
Macrophages and autophagy: partners in crime
Vitaliti, A., Reggio, A., & Palma, A. (2024) · FEBS Journal · doi:10.1111/febs.17305 · Cited by 25
Zhan, S., Wu, L., Lv, Y., Huang, W., Ge, C., Hu, Z., Shen, X., Lin, G., Yu, D., & Liu, B. (2025) · Poultry Science · doi:10.1016/j.psj.2025.104997 · Cited by 25
Rashed, K. N. Z., Potočnjak, I., Giacometti, J., Škoda, M., & Domitrović, R. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.03.033 · Cited by 25
Alshammari, G. M., Abdelhalim, M. A. K., Al-Ayed, M. S., Al‐Harbi, L. N., & Yahya, M. A. (2022) · Nutrients · doi:10.3390/nu14163327 · Cited by 25
Zhang, B., Roh, Y. S., Liang, S., Liu, C., Naiki, M., Masuda, K., & Seki, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114071 · Cited by 25
Liu, M., Wu, Q., Chen, P., Büchele, B., Bian, M., Dong, S., Huang, D., Ren, C., Zhang, Y., Hou, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100129 · Cited by 25
Wang, F., Liu, S., Du, T., Chen, H., Li, Z., & Yan, J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1682 · Cited by 25
Kang, H. J., Chung, D.-H., Sung, C. O., Yoo, S. H., Yu, E., Kim, N., Lee, S.-H., Song, J., Kim, C. J., & Choi, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15930 · Cited by 25
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms
Kim, G., & Kang, E. S. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679956 · Cited by 25
Cheng, N., Ju, W., Yin, M., Xu, J., Wang, Y., Chen, X., Nie, Z., & Yin, J. (2019) · Bioscience Reports · doi:10.1042/bsr20190251 · Cited by 25
You, S., Zhao, J., Ma, L., Tudimat, M., Zhang, S.-L., & Liu, T. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0135-4 · Cited by 25
Present and Future Perspectives in the Treatment of Liver Fibrosis
Cerrito, L., Galasso, L., Iaccarino, J., Pizzi, A., Termite, F., Esposto, G., Borriello, R., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2025) · Pharmaceuticals · doi:10.3390/ph18091321 · Cited by 29
Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma
Hsu, Y., Wu, C., & Lin, J. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.023 · Cited by 24
Comparison of the Hepatoprotective Effects of the Three Main Stilbenes from Mulberry Twigs.
Jia, Y.-N., Peng, Y.-L., Zhao, Y., Cheng, X., Zhou, Y., Chai, C., Zeng, L., Pan, M., & Xu, L. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b07245 · Cited by 22
Tao, H.-C., Chen, K., Wang, X., Chen, B., Zhao, W., Zheng, Y., & Yang, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00148 · Cited by 27
Sun, S., Jin, Y., Yang, J., Zhao, Z., & Rao, Q. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111638 · Cited by 24
Hu, S., Russell, J. O., Liu, S., Cao, C., McGaughey, J. J., Rai, R. P., Kosar, K., Tao, J., Hurley, E., Poddar, M., et al. (2021) · eLife · doi:10.7554/elife.71310 · Cited by 23
Insights on the NF-κB System Using Live Cell Imaging: Recent Developments and Future Perspectives
Kizilirmak, C., Bianchi, M. E., & Zambrano, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886127 · Cited by 23
Wang, Y., Ma, N., Xu, S., Huang, J., Ni, Q., Cao, H., Zheng, Q., Zhu, B., Xia, J., Zhang, F.-K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112340 · Cited by 24
TNF-Dependent Signaling Pathways in Liver Cancer: Promising Targets for Therapeutic Strategies?
Roderburg, C., Gautheron, J., & Luedde, T. (2012) · Digestive Diseases · doi:10.1159/000341700 · Cited by 24
Self-citationThe protective effect of vildagliptin in chronic experimental cyclosporine A-induced hepatotoxicity
El-Sherbeeny, N. A., & Nader, M. A. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0336 · Cited by 24
Wang, W., Luo, J., Sheng, W., Xue, J., Li, M., Ji, J., Liu, P., Zhang, X., Cao, J., & Zhang, S. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.021 · Cited by 24
Bernabé, B. P., Shin, S., Rios, P., Broadbelt, L. J., Shea, L. D., & Seidlits, S. K. (2016) · Integrative Biology · doi:10.1039/c6ib00093b · Cited by 24
Ren, K., Li, Z., Li, Y., Zhang, W., & Han, X. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21917 · Cited by 24
BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca2+]i-TGF-β-Smad2/3 pathway
Liu, W., Wang, X., Mei, Z., Gong, J., Huang, L., Gao, X., Zhao, Y., Ma, J., & Qian, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-01936-5 · Cited by 26
Zhang, B., Zhang, J., & Pan, J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4079 · Cited by 24
Lin, D., Sun, Z., Jin, Z., Lei, L., Liu, Y., Hu, B., Wang, B., Shen, Y. H., & Wang, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00773 · Cited by 24
Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells
Mathema, V. B., Chai่jaroenkul, W., & Na‐Bangchang, K. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13024 · Cited by 24
Al‐Massri, K. F., Ahmed, L. A., & El-Abhar, H. S. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2972 · Cited by 24
Impact of fine particulate matter on liver injury: evidence from human, mice and cells
Xiao, Y., Hu, J., Chen, R., Xu, Y., Pan, B., Gao, Y., Deng, Y., Li, W., Kan, H., & Chen, S. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133958 · Cited by 23
Ivashkin, V. T., Drapkina, O. M., Maevskaya, M. V., Raikhelson, K. L., Okovityi, S. V., Жаркова, М. С., Grechishnikova, V. R., Abdulganieva, D. I., Alekseenko, S. A., Ardatskaya, M. D., et al. (2025) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2025-35-1-94-152 · Cited by 29
Hepatic adaptation to chronic metabolic stress primes tumorigenesis
Tzouanas, C. N., Shay, J. E. S., Sherman, M. S., Rubin, A. J., Mead, B. E., Dao, T. T., Tao, J., Lehrich, B. M., Eng, G. M., Patterson-Fortin, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.031 · Cited by 32
Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice
Baglieri, J., Zhang, C., Liang, S., Liu, X., Nishio, T., Rosenthal, S. B., Dhar, D., Su, H., Cong, M., Jia, J., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.05.019 · Cited by 23
Abouzed, T. K., Althobaiti, F., Omran, A. F., Eldomany, E., El-Shazly, S. A., Alharthi, F. R., Elkattawy, A. M., Kahilo, K. A., & Dorghamm, D. A. (2021) · Toxicology Research · doi:10.1093/toxres/tfab118 · Cited by 26
Banerjee, A., Mukherjee, S., & Maji, B. K. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14092 · Cited by 23
Hochnadel, I., Hoenicke, L., Petriv, N., Neubert, L., Reinhard, E., Hirsch, T., Alfonso, J. C. L., Suo, H., Longerich, T., Geffers, R., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02222-z · Cited by 26
Zheng, W., Sun, Q., Li, L., Cheng, Y. H., Chen, Y., Lv, M., & Xiang, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109458 · Cited by 25
Growth differentiation factor 15: Emerging role in liver diseases
Li, Y., Zhang, J., Chen, S., Ke, Y., Ke, Y., & Chen, Y. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156727 · Cited by 23
Jeng, J., Tsai, M.-F., Tsai, H.-R., Chuang, L., Lin, Z., Hsieh, M., Chen, S., Chuang, W.-L., Wang, L., Yu, M., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.637 · Cited by 23
Hazem, S. H., Shaker, M. E., Ashamallah, S. A., & Ibrahim, T. M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.06.017 · Cited by 23
Teng, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.300 · Cited by 26
Enos, R. T., Velázquez, K. T., Carson, M. S., McClellan, J. L., Nagarkatti, P. S., Nagarkatti, M., Davis, J. M., & Murphy, E. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167979 · Cited by 23
Fibroblast growth factor 9 subfamily and the heart
Wang, S., Li, Y., Jiang, C., & Tian, H. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8652-3 · Cited by 23
Pulido, Á. D. M., de Gregorio, E., Chandra, S., Colell, A., Morales, A., Kronenberg, M., & Marí, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00391 · Cited by 22
Wan, C., Wu, M., Zhang, S., Chen, Y., & Lu, C. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22885 · Cited by 23
Deng, Y., Tang, K., Chen, R., Liu, Y., Nie, H., Wang, H., Zhang, Y., & Yang, Q. (2018) · Medicines · doi:10.3390/medicines5030106 · Cited by 23
Macías-Pérez, J. R., Vázquez-López, B. J., Muñoz‐Ortega, M. H., Aldaba-Muruato, L. R., Martínez-Hernández, S. L., Sánchez‐Alemán, E., & Ventura‐Juárez, J. (2019) · Journal of Immunology Research · doi:10.1155/2019/3019794 · Cited by 23
Zhang, J., Zhao, Z., Bai, H., Wang, M., Jiao, L., Peng, W., Wu, T., Liu, T., Chen, H., Song, X., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222033 · Cited by 23
Improvement Effect of Lotus Leaf Flavonoids on Carbon Tetrachloride-Induced Liver Injury in Mice
Liu, T., Tan, F., Long, X., Pan, Y., Mu, J., Zhou, X., Yi, R., & Zhao, X. (2020) · Biomedicines · doi:10.3390/biomedicines8020041 · Cited by 23
HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats
Moczydłowska, J. M., Miltyk, W., Hermanowicz, A., Lebensztejn, D. M., Palka, J. A., & Dębek, W. (2016) · Journal of Investigative Surgery · doi:10.1080/08941939.2016.1183734 · Cited by 23
Soong, R.-S., Anchoori, R. K., Roden, R. B. S., Cho, R., Chen, Y.-C., Tseng, S.-C., Huang, Y.-L., Liao, P.-C., & Shyu, Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-06896-0 · Cited by 22
Kwon, S. M., Lee, Y., Min, S., Woo, H. G., Wang, H.-J., & Yoon, G. (2020) · iScience · doi:10.1016/j.isci.2020.101247 · Cited by 22
Qu, S., Dai, C., Hao, Z., Tang, Q., Wang, H., Wang, J., & Zhao, H. (2020) · Phytotherapy Research · doi:10.1002/ptr.6765 · Cited by 22
Metabolic Profiling of Bile Acids in the Urine of Patients with Alcohol-Associated Liver Disease
He, L., Vatsalya, V., Ma, X., Zhang, J., Yin, X., Kim, S., Feng, W., McClain, C. J., & Zhang, X. (2021) · Hepatology Communications · doi:10.1002/hep4.1671 · Cited by 22
Shalkami, A. S., Hassanein, E. H. M., Sayed, A. M. M., Mohamed, W. R., Khalaf, M. M., & Hemeida, R. A. M. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15358-4 · Cited by 22
Sun, Y., Ma, N., Liu, X., Yi, J., & Cai, S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104830 · Cited by 22
Mohamed, A. E., Mahmoud, A. M., Mohamed, W. R., & Mohamed, T. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120877 · Cited by 22
Wang, Z., Zhang, Y., Zhang, Q., Ao, Q., Luo, C., Wang, B., Bai, C., Ge, X., Wang, Y., Wang, J., et al. (2022) · Journal of Oncology · doi:10.1155/2022/5300523 · Cited by 25
Fujiwara, S., Izawa, T., Mori, M., Atarashi, M., Yamate, J., & Kuwamura, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-25838-3 · Cited by 22
Metadata
- Authors
- Luedde, T., & Schwabe, R. F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Luedde, Tom
- Schwabe, Robert F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-118
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC3295539
- OpenAlex
- W1976777085
- Cited by
- 1,345
- References
- 137
- Citations by year
- 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u54ca126513-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54 CA126513.)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
- National Center for Complementary and Integrative Health (R21AT003878)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
- MeSH terms
- Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
